We have previously shown that intramuscular delivery of an adenovirus expressing Cre recombinase into mice with conditional mutations in Kras and Trp53 results in the formation of soft tissue sarcomas at the site of injection3. The gene discussed is KRAS; the disease is soft tissue sarcoma.